Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

NICHIBAN

IBIDEN

TOC

Soda Aromatic

kikusui chemical industries

SHOEI

AGRO-KANESHO.

堺化学工業

TERAOKA SEISAKUSHO

NIHON KAGAKU SANGYO

ロックペイント

ISE CHEMICALS

RIKEN TECHNOS

医学生物学研究所

ARAKAWA CHEMICAL INDUSTRIES

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

Nittetsu Mining

Renesas Electronics

PIONEER etc.

KIKUSUI ELECTRONICS etc.

Financial Indicator Details: カーリットホールディングス (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: カーリットホールディングス (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	3.93% (-12.05%)	3.00% (-0.50%)	4.15% (1.53%)	2.91% (-1.67%)	4.24% (3.05%)
C/F margin (Industry Average)	7.78% (-3.31%)	6.79% (8.51%)	13.16% (7.04%)	8.55% (6.35%)	3.73% (8.25%)
ROA (Industry Average)	4.18% (0.52%)	2.80% (1.04%)	3.90% (2.07%)	3.06% (0.06%)	4.38% (2.71%)
ROE (Industry Average)	9.21% (-1.43%)	6.10% (0.03%)	8.58% (2.96%)	6.53% (4.68%)	9.12% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	8.61% (5.01%)	6.45% (2.61%)	5.12% (-0.40%)	11.18% (8.16%)
Sales growth (Industry Average)	- (-)	-5.93% (-2.67%)	8.39% (5.36%)	14.24% (1.07%)	6.41% (2.24%)
Net profit growth (Industry Average)	- (-)	-28.10% (203.46%)	49.74% (63.25%)	-19.87% (3.89%)	55.15% (90.38%)
Operating C/F growth (Industry Average)	- (-)	-17.98% (275.10%)	110.11% (35.09%)	-25.70% (-6.09%)	-53.60% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	45.37% (53.80%)	45.99% (54.51%)	45.56% (55.00%)	46.93% (53.59%)	48.06% (56.30%)
Liquidity ratio (Industry Average)	98.54% (217.72%)	114.06% (225.70%)	119.20% (237.55%)	119.38% (239.89%)	137.71% (236.21%)
C/F ratio current liabilities (Industry Average)	494.73% (777.21%)	573.37% (303.31%)	271.03% (434.79%)	394.40% (929.73%)	821.53% (573.30%)
Quick ratio (Industry Average)	63.35% (138.97%)	74.74% (148.85%)	81.87% (156.17%)	91.44% (160.84%)	104.63% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	68.47day (83.89day)	77.72day (94.27day)	66.31day (93.96day)	92.84day (97.92day)	89.50day (98.27day)
Inventory turnover (Industry Average)	42.61day (54.45day)	43.99day (52.58day)	37.28day (52.64day)	28.11day (56.59day)	27.64day (58.68day)
Payable turnover (Industry Average)	42.11day (45.01day)	43.30day (49.82day)	39.99day (49.52day)	62.18day (52.10day)	54.41day (51.12day)
Working capita turnover (Industry Average)	68.97day (93.32day)	78.40day (97.02day)	63.60day (97.08day)	58.78day (102.41day)	62.73day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	32.14% (34.57%)	2.94% (1.49%)	-7.94% (-3.85%)	23.98% (21.16%)
Dividend Yield (Industry Average)	2.84% (3.20%)	2.03% (1.93%)	1.98% (2.17%)	2.33% (2.45%)	1.87% (2.07%)
PER (Industry Average)	5.75% (25.22%)	10.57% (23.06%)	7.27% (16.22%)	8.35% (29.19%)	6.67% (16.58%)
PBR (Industry Average)	0.53% (0.86%)	0.64% (1.06%)	0.62% (1.04%)	0.54% (0.95%)	0.60% (1.08%)
PCFR (Industry Average)	2.90% (7.18%)	4.68% (9.23%)	2.29% (-2.43%)	2.84% (9.50%)	7.59% (7.56%)
PSR (Industry Average)	0.22% (0.77%)	0.31% (0.88%)	0.30% (1.10%)	0.24% (0.90%)	0.28% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	7.09% (-27.66%)	11.72% (-4.34%)	8.16% (-5.37%)	8.11% (-10.69%)	11.89% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	3.72% (0.52%)	5.25% (0.92%)	3.45% (1.42%)	3.38% (-0.27%)	4.78% (1.53%)
ROE (Industry Average)	8.28% (-0.84%)	11.38% (-0.46%)	7.18% (1.81%)	6.79% (3.42%)	9.31% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	15.29% (3.64%)	3.72% (3.03%)	5.21% (0.04%)	11.04% (3.91%)
Sales growth (Industry Average)	- (-)	-4.17% (-3.48%)	-5.92% (6.70%)	0.05% (0.75%)	3.84% (-1.74%)
Net profit growth (Industry Average)	- (-)	58.36% (166.48%)	-34.52% (43.48%)	-0.50% (-47.04%)	52.24% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	44.90% (56.79%)	46.14% (57.65%)	48.14% (57.17%)	49.82% (55.93%)	51.33% (57.57%)
Liquidity ratio (Industry Average)	96.96% (337.22%)	120.69% (276.75%)	132.42% (266.94%)	127.09% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	48.69% (167.28%)	57.44% (183.78%)	72.18% (174.83%)	66.87% (228.06%)	- (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	95.92day (87.55day)	108.67day (98.39day)	100.26day (95.88day)	115.04day (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	46.50day (50.17day)	47.89day (48.43day)	55.25day (47.43day)	42.65day (50.67day)	- (38.21day)
Payable turnover (Industry Average)	46.73day (45.70day)	47.43day (51.63day)	41.50day (51.13day)	62.40day (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	95.69day (92.02day)	109.13day (95.19day)	114.01day (92.19day)	95.28day (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	32.14% (34.46%)	2.94% (3.11%)	-7.94% (-3.30%)	23.98% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	7.23% (34.12%)	6.03% (27.80%)	9.49% (13.58%)	8.78% (22.26%)	7.15% (26.42%)
PBR (Industry Average)	0.59% (0.97%)	0.68% (1.21%)	0.68% (1.17%)	0.59% (1.08%)	0.66% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.51% (3.42%)	0.70% (4.34%)	0.77% (3.67%)	0.71% (4.37%)	0.85% (10.14%)

Financial Indicator Details: カーリット HLDGS

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	3.93%	3.00%	4.15%	2.91%	4.24%
C/F margin	7.78%	6.79%	13.16%	8.55%	3.73%
ROA	4.18%	2.80%	3.90%	3.06%	4.38%
ROE	9.21%	6.10%	8.58%	6.53%	9.12%
Recurring margin	5.53%	5.42%	6.46%	4.66%	4.05%
EBIT margin	7.00%	4.79%	5.89%	5.00%	7.27%
EBITDA margin	11.92%	9.52%	10.30%	9.22%	11.04%
NOPAT margin	4.20%	2.87%	3.53%	3.00%	4.36%
Sales SG rates	84.48%	84.14%	82.94%	85.92%	85.27%
Sales SG&A rates	10.93%	10.85%	10.55%	9.75%	11.03%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	4.91%	4.72%	4.40%	4.21%	3.76%
Capital expenditures net sales ratio	-6.27%	-5.88%	-5.08%	-3.83%	-4.37%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	29.99%	53.25%	-43.75%	47.93%
Equity growth	-	8.61%	6.45%	5.12%	11.18%
Total assets growth	-	7.13%	7.46%	2.07%	8.57%
Sales growth	-	-5.93%	8.39%	14.24%	6.41%
Net profit growth	-	-28.10%	49.74%	-19.87%	55.15%
Operating C/F growth	-	-17.98%	110.11%	-25.70%	-53.60%
Recurring profit growth	-	-7.70%	29.08%	-17.47%	-7.46%
EBIT growth	-	-35.56%	33.21%	-3.01%	54.53%
EBITDA growth	-	-24.88%	17.27%	2.32%	27.33%
NOPAT growth	-	-35.56%	33.21%	-3.01%	54.53%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	45.37%	45.99%	45.56%	46.93%	48.06%
Liquidity ratio	98.54%	114.06%	119.20%	119.38%	137.71%
C/F ratio current liabilities	494.73%	573.37%	271.03%	394.40%	821.53%
Quick ratio	63.35%	74.74%	81.87%	91.44%	104.63%
Fixed ratio	98.37%	92.08%	100.40%	95.46%	89.09%
D/E ratio	56.63%	53.12%	44.14%	37.40%	37.20%
Loan to Value Ratio	25.69%	24.43%	20.11%	17.55%	17.88%
Business investment C/F ratio	-80.56%	-86.69%	-38.60%	-44.85%	-117.33%
Liabilities with interest growth	-	1.88%	-11.53%	-10.91%	10.57%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	20.62day	28.49day	40.29day	19.83day	27.57day
Receivables turnover	68.47day	77.72day	66.31day	92.84day	89.50day
Inventory turnover	42.61day	43.99day	37.28day	28.11day	27.64day
Fixed assets turnover	153.19day	165.57day	177.32day	155.15day	151.29day
Total asset turnover	343.22day	390.91day	387.57day	346.27day	353.31day
Payable turnover	42.11day	43.30day	39.99day	62.18day	54.41day
Capital turnover	14.50day	15.42day	14.22day	12.45day	11.70day
Equity turnover	155.73day	179.81day	176.61day	162.52day	169.81day
Working capita turnover	68.97day	78.40day	63.60day	58.78day	62.73day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 1 B	¥ 2 B	¥ 3 B	¥ 1 B	¥ 2 B
Accounts receivable-trade	¥ 5 B	¥ 6 B	¥ 5 B	¥ 8 B	¥ 9 B
Other Current Assets	¥ 9 B	¥ 10 B	¥ 9 B	¥ 12 B	¥ 13 B
Current Assets	¥ 11 B	¥ 12 B	¥ 13 B	¥ 14 B	¥ 15 B
Tangible Assets	¥ 12 B	¥ 12 B	¥ 15 B	¥ 15 B	¥ 15 B
Intangible Assets	¥ 59 M	¥ 42 M	¥ 35 M	¥ 68 M	¥ 66 M
Investment etc.	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Total Assets	¥ 28 B	¥ 30 B	¥ 32 B	¥ 33 B	¥ 36 B
Current Liabilities	¥ 11 B	¥ 11 B	¥ 11 B	¥ 11 B	¥ 11 B
Fixed Liabilities	¥ 3 B	¥ 5 B	¥ 6 B	¥ 5 B	¥ 7 B
Liabilities with interest	¥ 7 B	¥ 7 B	¥ 6 B	¥ 5 B	¥ 6 B
Net Assets	¥ 12 B	¥ 14 B	¥ 14 B	¥ 15 B	¥ 17 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 11 B	¥ 12 B	¥ 13 B	¥ 14 B	¥ 16 B
Liabilities and net assets	¥ 28 B	¥ 30 B	¥ 32 B	¥ 33 B	¥ 36 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 30 B	¥ 28 B	¥ 30 B	¥ 35 B	¥ 37 B
Cost of Sales	¥ 25 B	¥ 23 B	¥ 25 B	¥ 30 B	¥ 32 B
Gross profit	¥ 4 B	¥ 4 B	¥ 5 B	¥ 4 B	¥ 5 B
Other income	¥ 1 B	¥ 245 M	¥ 173 M	¥ 369 M	¥ 1 B
SG&A	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Other expenses	¥ 1 B	¥ 828 M	¥ 868 M	¥ 875 M	¥ 1 B
Net income	¥ 1 B	¥ 856 M	¥ 1 B	¥ 1 B	¥ 1 B
Operating income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B
Ordinary Income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
EBITDA	¥ 3 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 4 B
Income before income taxes	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Depreciation	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 789 M	¥ 436 M	¥ 396 M	¥ 652 M	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 2 B	¥ 1 B	¥ 4 B	¥ 3 B	¥ 1 B
Investment CF	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Financial CF	¥ -444 M	¥ 29 M	¥ -1 B	¥ -3 B	¥ 837 M
Foreign Exchange Effects	-	-	¥ -3 M	¥ 1 M	¥ 30 M
Net Change in Cash	¥ 306 M	¥ 116 M	¥ 1 B	¥ -1 B	¥ 807 M
Free CF	¥ 751 M	¥ 87 M	¥ 2 B	¥ 1 B	¥ -61 M
Capital expenditures	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Cash dividends paid	¥ -195 M	¥ -184 M	¥ -185 M	¥ -200 M	¥ -199 M
Repayment loans	¥ -997 M	¥ -996 M	¥ -371 M	¥ -696 M	¥ -739 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -185 M	¥ -185 M	¥ -185 M	¥ -185 M	¥ -185 M
Net income	¥ 1 B	¥ 856 M	¥ 1 B	¥ 1 B	¥ 1 B
Purchase of treasury stock	¥ 1 M	¥ 114 K	¥ -25 K	¥ -71 K	¥ -75 K
Other Change in Stockholders Equity	¥ -1 K	¥ -2 M	¥ -1 K	¥ -1 K	¥ 1 K
Other Change in Net Assets	¥ -874 M	¥ 444 M	¥ -189 M	¥ -76 M	¥ 349 M
Net Change in Net Assets	¥ 132 M	¥ 1 B	¥ 908 M	¥ 766 M	¥ 1 B

Financial Indicator Details: カーリット HLDGS

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	7.09%	11.72%	8.16%	8.11%	11.89%
C/F margin	-	-	-	-	-
ROA	3.72%	5.25%	3.45%	3.38%	4.78%
ROE	8.28%	11.38%	7.18%	6.79%	9.31%
Recurring margin	9.25%	11.53%	11.79%	9.47%	8.37%
EBIT margin	11.70%	15.27%	9.32%	10.00%	-
EBITDA margin	11.70%	15.27%	9.32%	10.00%	-
NOPAT margin	7.02%	9.16%	5.59%	6.00%	-
Sales SG rates	72.85%	70.51%	67.75%	69.72%	88.10%
Sales SG&A rates	19.14%	19.44%	21.74%	22.81%	-
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	-	-	-	-	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	12.53%	99.53%	-54.97%	-100.00%
Equity growth	-	15.29%	3.72%	5.21%	11.04%
Total assets growth	-	12.20%	-0.58%	1.65%	7.79%
Sales growth	-	-4.17%	-5.92%	0.05%	3.84%
Net profit growth	-	58.36%	-34.52%	-0.50%	52.24%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	19.41%	-3.77%	-19.63%	-8.23%
EBIT growth	-	25.03%	-42.54%	7.30%	-100.00%
EBITDA growth	-	25.03%	-42.54%	7.30%	-100.00%
NOPAT growth	-	25.03%	-42.54%	7.30%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	44.90%	46.14%	48.14%	49.82%	51.33%
Liquidity ratio	96.96%	120.69%	132.42%	127.09%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	48.69%	57.44%	72.18%	66.87%	-
Fixed ratio	88.73%	80.59%	80.57%	78.10%	-
D/E ratio	63.77%	56.56%	48.24%	40.84%	-
Loan to Value Ratio	28.63%	26.10%	23.22%	20.35%	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	2.26%	-11.53%	-10.91%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	35.83day	42.08day	89.26day	40.17day	-
Receivables turnover	95.92day	108.67day	100.26day	115.04day	-
Inventory turnover	46.50day	47.89day	55.25day	42.65day	-
Fixed assets turnover	277.32day	303.07day	334.07day	340.56day	-
Total asset turnover	695.96day	814.97day	861.28day	875.01day	908.25day
Payable turnover	46.73day	47.43day	41.50day	62.40day	-
Capital turnover	32.90day	34.33day	36.50day	36.47day	-
Equity turnover	312.52day	376.04day	414.63day	436.01day	466.21day
Working capita turnover	95.69day	109.13day	114.01day	95.28day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	-
Accounts receivable-trade	¥ 3 B	¥ 3 B	¥ 3 B	-	-
Other Current Assets	¥ 8 B	¥ 9 B	¥ 8 B	¥ 8 B	-
Current Assets	¥ 9 B	¥ 11 B	¥ 11 B	-	-
Tangible Assets	¥ 10 B	¥ 10 B	¥ 11 B	¥ 11 B	-
Intangible Assets	¥ 50 M	¥ 34 M	¥ 25 M	¥ 28 M	-
Investment etc.	¥ 5 B	¥ 6 B	¥ 5 B	¥ 7 B	¥ 31 B
Total Assets	¥ 25 B	¥ 28 B	¥ 28 B	¥ 28 B	¥ 31 B
Current Liabilities	¥ 9 B	¥ 9 B	¥ 8 B	¥ 7 B	¥ 15 B
Fixed Liabilities	¥ 4 B	¥ 6 B	¥ 6 B	¥ 6 B	-
Liabilities with interest	¥ 7 B	¥ 7 B	¥ 6 B	¥ 5 B	-
Net Assets	¥ 11 B	¥ 13 B	¥ 13 B	¥ 14 B	¥ 15 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	-
Capital surplus etc.	¥ 10 B	¥ 11 B	¥ 12 B	¥ 13 B	¥ 15 B
Liabilities and net assets	¥ 25 B	¥ 28 B	¥ 28 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 13 B	¥ 12 B	¥ 12 B	¥ 12 B	¥ 12 B
Cost of Sales	¥ 9 B	¥ 9 B	¥ 8 B	¥ 8 B	¥ 11 B
Gross profit	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 1 B
Other income	¥ 800 M	¥ 1 B	¥ 256 M	¥ 479 M	-
SG&A	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	-
Other expenses	¥ 921 M	¥ 795 M	¥ 537 M	¥ 400 M	-
Net income	¥ 947 M	¥ 1 B	¥ 983 M	¥ 978 M	¥ 1 B
Operating income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 899 M	¥ 722 M
Ordinary Income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
EBITDA	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	-
Income before income taxes	¥ 1 B	¥ 1 B	¥ 1 B	-	-
Depreciation	-	-	-	-	-
R&D expenses	-	-	-	-	-
Income taxes	¥ 577 M	¥ 436 M	¥ 117 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -185 M	¥ -185 M	¥ -185 M	-	-
Net income	¥ 947 M	¥ 1 B	¥ 983 M	-	-
Purchase of treasury stock	¥ -109 K	¥ -68 K	¥ -25 K	-	-
Other Change in Stockholders Equity	-	¥ -1 K	-	¥ -1 K	-
Other Change in Net Assets	¥ -876 M	¥ 434 M	¥ -306 M	-	-
Net Change in Net Assets	¥ -113 M	¥ 1 B	¥ 491 M	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: カーリットホールディングス (Annual )

Statement Type

Annual : カーリットホールディングス

First quarter : カーリットホールディングス

Second quarter : カーリットホールディングス

Third quarter : カーリットホールディングス

Analysis Menu

Outline : カーリットホールディングス

Statement : カーリットホールディングス

Rating : カーリットホールディングス

Indicator : カーリットホールディングス

Download : カーリットホールディングス

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo千代田区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
カーリットホールディングス	4275	TSE 1st	Chemicals	3	Annual	A

Related Company

医学生物学研究所 (Sales ¥ 6 B)

SHOEI (Sales ¥ 11 B)

kikusui chemical industries (Sales ¥ 19 B)

TOC (Sales ¥ 20 B)

MAEZAWA KASEI INDUSTRIES (Sales ¥ 21 B)

AGRO-KANESHO. (Sales ¥ 11 B)

NIHON KAGAKU SANGYO (Sales ¥ 17 B)

IBIDEN (Sales ¥ 285 B)

TIGERS POLYMER (Sales ¥ 29 B)

NICHIBAN (Sales ¥ 38 B)

JCR Pharmaceuticals (Sales ¥ 14 B)

ソフト９９コーポレーション (Sales ¥ 21 B)

SEIKO PMC (Sales ¥ 21 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .